teaser
Macmillan Cancer Support has published a new report praising the Cancer Drugs Fund for improving access to vital medicines for cancer patients.
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
However, the report bemoans the lack of plans to ensure that cancer patients will continue to receive treatment once the Fund ends in 2014 and a new Value-Based Pricing System is introduced.
Mike Hobday, Senior Public Affairs Officer at Macmillan, who co-wrote the report, said:
